Browse/Specialty Dietary Substance
Specialty Dietary Substance

R-Lipoic Acid (Stabilized Na-RALA)

01 / OVERVIEW

What this compound does

WHAT IT DOES

R-Lipoic acid is a special form of a natural antioxidant that your body makes in small amounts. It works inside your cells to protect them from damage, especially in parts that produce energy. Taking it as a supplement helps your body use sugar for energy more effectively, which can support steady blood sugar levels and reduce stress on your cells. This stabilized version (Na-RALA) is better absorbed and stays in your system longer than regular lipoic acid. People often take it to boost energy, protect nerves, and support healthy aging. It's like giving your body's power plants extra armor and a tune-up at the same time. Most people start noticing benefits like more consistent energy and less fatigue within a few weeks, though some effects on blood sugar may be felt sooner.

KEY BENEFITS
Protects cells from oxidative damage
Supports healthy blood sugar levels
Boosts natural antioxidant defenses
May reduce nerve pain and tingling
Improves energy production in cells
Helps recycle other antioxidants like vitamin C
BEST FOR
  • • Adults with blood sugar concerns or insulin resistance
  • • People with nerve pain or diabetic neuropathy
  • • Older adults looking to support cellular health
  • • Athletes seeking better recovery and energy metabolism
  • • Those with metabolic syndrome or elevated oxidative stress
WHAT TO EXPECT

You may notice subtle improvements in energy and mental clarity within 1–2 weeks. For blood sugar support or nerve symptoms, it may take 4–8 weeks to feel noticeable changes.

WHO SHOULD AVOID THIS
  • • Pregnant or breastfeeding women (insufficient safety data)
  • • People with thiamine deficiency (may worsen condition)
  • • Individuals on chemotherapy (possible interference)
  • • Those with a history of autoimmune disease (stimulates immune system)
  • • Children (no established safe dose)
MYTHS & FACTS
Myth: R-Lipoic acid is the same as regular alpha-lipoic acid (ALA).
Fact: Regular ALA is a 50/50 mix of R and S forms. Only the R-form is biologically active and produced naturally. Na-RALA is a stabilized, more bioavailable version of the active R-isomer, making it more effective at lower doses.
Myth: You can get enough R-lipoic acid from food.
Fact: Dietary sources (spinach, broccoli, organ meats) provide only tiny amounts of ALA. Supplementation is needed to reach therapeutic levels for antioxidant and metabolic benefits.
Myth: Higher doses are always better for antioxidant protection.
Fact: Very high doses (over 600 mg/day) may paradoxically increase oxidative stress due to pro-oxidant effects. The optimal range for most benefits is 100–300 mg/day of Na-RALA.
At a glance
Typical dose
300-600 mg/day
Loading: 600-900 mg/day × 5-7 days for acute antioxidant/neuropathy benefits
Evidence
—
Studies indexed6
How it's made

Production details below.

03 / DOSAGE

How much, when

MAINTENANCE

300-600 mg/day

LOADING PROTOCOL

600-900 mg/day × 5-7 days for acute antioxidant/neuropathy benefits

Take on empty stomach (30 min before meals) or with small amount of food if GI tolerance is an issue; avoid taking with high-fiber meals which may impair absorption

TIMING

R-Lipoic Acid (Stabilized Na-RALA) — Any dose

Take with food (high-fat meal)

02 / EVIDENCE

Peer-reviewed studies

  • PMID: 14517944

    Improves insulin sensitivity

    In a 4-week RCT, 600 mg/day racemic ALA improved insulin sensitivity by 25% in type 2 diabetics (n=74). Na-RALA likely more potent.

    A
  • PMID: 22473703

    Reduces diabetic neuropathy pain

    Meta-analysis of 15 RCTs (n=1,258) found that IV ALA (600 mg/day) significantly improved neuropathic symptoms; oral ALA showed modest benefit.

    A
  • PMID: 25320066

    Antioxidant capacity increase

    Study with Na-RALA (300 mg/day for 8 weeks) increased total antioxidant capacity by 18% and reduced oxidative stress markers in healthy adults (n=30).

    B
  • PMID: 25670821

    Lowers blood glucose in prediabetes

    RCT of 100 patients with prediabetes: 300 mg ALA/day for 12 weeks reduced fasting glucose by 12 mg/dL and HbA1c by 0.4%.

    B
  • PMID: 23475497

    Supports weight loss

    Combined with lifestyle, ALA (1,200 mg/day) for 20 weeks resulted in 3.8 kg weight loss vs. 2.1 kg placebo (n=360). Mechanism unclear.

    B
  • PMID: 12611891

    Improves mitochondrial function in aging

    In aged mice, R-ALA restored mitochondrial membrane potential and reduced oxidative damage; human data limited.

    C
  • PMID 37686725 · 2023RCT

    Novel Multi-Ingredient Supplement Facilitates Weight Loss and Improves Body Composition in Overweight and Obese Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    B
  • PMID 38138300 · 2023RCT

    Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial

    B
  • PMID 29753588 · 2018Meta-Analysis

    Effects of alpha-lipoic acid supplementation on C-reactive protein level: A systematic review and meta-analysis of randomized controlled clinical trials

    B
  • PMID 33299302 · 2020Safety Study

    Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention

    B
  • PMID 32580620 · 2021Mechanistic Study

    The effect of alpha-lipoic acid supplementation and electrical isotonic contraction on anthropometric parameters, body composition and angiogenesis factor, sirtunin-1 and peroxisome proliferator-activated receptor-γ coactivator-1α in obese people under a weight loss regime: A study protocol for a randomized controlled clinical trial

    B
04 / INTERACTIONS

Medicine interactions

  • Chemotherapy (e.g., cisplatin)· antineoplastic

    Antioxidant may reduce chemotherapy efficacy by protecting cancer cells.

    → Avoid complementary use during chemotherapy unless approved by oncologist.

    HIGH

  • Metformin· antidiabetic

    Additive effects on blood glucose lowering.

    → Monitor blood glucose; may need to adjust metformin dose.

    MODERATE

  • Insulin· antidiabetic

    R-ALA increases insulin sensitivity, potentiating insulin's effect.

    → Monitor glucose closely; insulin dose may need reduction.

    MODERATE

  • Thyroid hormones (levothyroxine)· thyroid_med

    R-ALA may slightly impair thyroid hormone absorption or metabolism.

    → Separate doses by at least 3 hours; monitor thyroid function.

    LOW

  • Warfarin· blood_thinner

    Theoretical risk of reduced anticoagulant effect due to antioxidant activity.

    → Monitor INR if combining; limited evidence.

    LOW

This page is a reference summary, not a prescription. Consult a clinician before starting, stopping, or combining supplements — especially if you take medication or have a medical condition.